Medical Oncologist
CION Cancer Clinics
Three months or six months of chemotherapy after colon cancer surgery? | CION Cancer Clinics
For many people with lower-risk stage 3 colon cancer, three months of oxaliplatin-based chemotherapy protects about as well as six, with far less lasting numbness in the hands and feet. For higher-risk stage 3, six months usually keeps a small edge. This page explains how your oncologist weighs the stage, the combination and the side effects you develop, so you can follow the decision rather than simply receive it. At CION Cancer Clinics, a multidisciplinary team plans colon cancer treatment for your stage, from surgery to chemotherapy and follow-up.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Is three months of chemotherapy enough after colon surgery?
- How do the two lengths compare?
- What decides whether you need three months or six?
- How does your team settle on a length, and when can it change?
- What do families get wrong about the length of chemotherapy?
- What this page cannot tell you
- Common questions about three versus six months
The short answer
Is three months of chemotherapy enough after colon surgery?
For many people with lower-risk stage 3 colon cancer, yes. Large international trials found that three months of oxaliplatin-based chemotherapy protected about as well as six for this group, with far less lasting nerve damage. For higher-risk stage 3, six months usually still has a small edge.
What the question is really about
Chemotherapy after a colon operation is called adjuvant chemotherapy. It mops up cancer cells too small to see on any scan. The usual combinations pair oxaliplatin, given as a drip, with capecitabine tablets or a 5-FU pump. Oxaliplatin is the drug that damages nerves, and that damage builds with every dose. So the length of the course is a trade between a little extra protection and a lasting effect on your hands and feet.
What the trials actually compared
Six trials from different countries were pooled so that thousands of people could be compared. The shorter course was clearly gentler. Whether it protected as well depended on two things: how far the cancer had reached, and which combination was used. That is why your oncologist asks about both before suggesting a length.
Length is decided on your pathology report, never on what a relative or neighbour was given.Side by side
How do the two lengths compare?
Three months
Six months
Often chosen for lower-risk stage 3, especially with CAPOX
Often advised for higher-risk stage 3, especially with FOLFOX
Much less long-lasting numbness and tingling
More nerve symptoms, which stay for years in some people
Fewer hospital visits and less time away from work
Twice as many cycles, blood tests and journeys
Protection close to six months in lower-risk disease
A small extra benefit in higher-risk disease
Not sure whether this applies to you?
Ask an oncologistFour things your team weighs
What decides whether you need three months or six?
No single factor settles it. Your oncologist puts these four together, and the answer can change as treatment goes on.
How far the cancer had reached
The pathology report on the removed bowel gives a T stage, meaning how deep the tumour grew through the bowel wall, and an N stage, meaning how many lymph nodes (small glands that filter fluid) contained cancer.
Usually treated as higher risk
- T4: grown through the outer wall or into a nearby organ
- N2: cancer in four or more lymph nodes
What oxaliplatin does to your nerves
Tingling set off by cold drinks is common early and usually passes within days. Numbness that stays between cycles and makes buttons, writing or walking harder is the warning sign. When it appears, oxaliplatin is often stopped and the other drug carries on.
Your age, fitness and other illnesses
Diabetes that has already affected the feet, kidney problems and frailty all shift the balance. In older people the added benefit of oxaliplatin is less certain, and some are offered capecitabine alone, which is usually given for six months.
How it is decided
How does your team settle on a length, and when can it change?
The pathology report arrives
It gives the T and N stage, how many lymph nodes were examined, and the MMR result, a test of whether the tumour's DNA repair system works. All of these feed the decision.
The tumour board recommends a plan
At CION, medical, surgical and radiation oncologists review the report and scans together. They suggest a combination and a planned length, with the reasons written down.
You talk it through
Your oncologist explains the trade in plain words. Your work, your diabetes, the travel from your district and your own wishes all count. Bring a family member who will help you remember.
It is checked at every cycle
Before each dose you are asked about tingling, numbness and balance. A six-month plan can drop oxaliplatin early. A three-month plan rarely needs to be extended.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families get wrong about the length of chemotherapy?
"More chemotherapy always means more protection."
Not past a certain point. For lower-risk stage 3 treated with CAPOX, the extra three months added very little protection and a great deal more nerve damage. The longer course earns its place mainly when the cancer had reached further.
"Three months is a cheap short cut."
It is a plan built on pooled trials involving thousands of people. It is chosen because it protects about as well for the right person. The lower bill is a side benefit, not the reason.
"If oxaliplatin is stopped early, the treatment has failed."
Stopping it for numbness is planned for from the start. The tablets or pump usually continue to the end of the course. Protecting your hands and feet for the rest of your life is part of good treatment, not a retreat from it.
"The numbness will disappear the day chemotherapy ends."
It often gets slightly worse for a few weeks after the last dose, then improves slowly. In some people it never fully goes, which is exactly why the length of the course matters.
Being straight with you
What this page cannot tell you
It cannot tell you how long your own course should be. That depends on the exact wording of your pathology report, your blood tests, the combination your oncologist suggests and how your nerves respond once treatment starts. A page that ignores those details would be guessing.
Who this does not apply to
The three-or-six question belongs mainly to stage 3 colon cancer, and to some stage 2 cancers with high-risk features. Most stage 1 and many stage 2 cancers need no chemotherapy at all. In stage 4, chemotherapy is planned around scans rather than a fixed length. Cancer of the rectum follows a different pathway with radiation in many cases, so read the rectal cancer section instead.
Who can answer it
Your medical oncologist, with the tumour board behind them. If you were offered six months and wonder whether three would do, or the other way round, ask why. A good answer names your T stage, your N stage and the combination.
If the explanation you were given did not make sense, a second opinion on the length is a reasonable request.Questions we are asked
Common questions about three versus six months
Is three months of chemotherapy enough for stage 3 colon cancer?
For lower-risk stage 3, meaning the tumour had not grown through the outer bowel wall and three or fewer nodes were involved, three months of CAPOX is now a standard choice. For higher-risk stage 3, six months is usually advised. Your pathology report decides which group you are in.
Why was my relative given three months when I was told six?
The two cancers were probably staged differently, or treated with different combinations. A T4 tumour, four or more involved nodes, or the use of FOLFOX all tilt the advice towards six months. Ask your oncologist which of these applies to you.
Does the shorter course work as well with FOLFOX?
Less clearly. In the pooled trials, three months held up best with CAPOX. With FOLFOX, six months kept a small advantage. Some people still have FOLFOX for three months because of side effects or personal circumstances, after a frank discussion of the trade.
Can I change from six months to three halfway through?
Often the oxaliplatin is stopped early because of numbness, while the tablets or pump continue. Whether to stop everything at three months is a decision for your oncologist, based on your stage and how you are coping. Do not stop on your own.
I have stage 2 colon cancer. Does this apply to me?
Only if your cancer has high-risk features and your team recommends chemotherapy at all. Many stage 2 cancers need none. When it is given for high-risk stage 2, three months of CAPOX is often considered. The stage 2 decision has its own page on this site.
Will the numbness from oxaliplatin go away?
For most people it improves slowly over the months after treatment ends. For some it stays, mildly or more. The total amount of oxaliplatin given is the main thing that predicts how much is left, which is why the shorter course is so attractive when it is safe.
Does three months cost less than six?
Yes, because fewer cycles, blood tests and visits are needed, and less time is lost from work. Cost should never be the reason for choosing the shorter course. Ask for a written estimate for the length you are actually recommended, and check what your insurance or scheme covers.
Can I get a second opinion on the length of my chemotherapy?
Yes. Bring your pathology report, your scan reports and your discharge summary. A CION medical oncologist can review them and explain whether the length you were offered fits your stage. Call the helpline to arrange it, ideally before your second cycle.
Your Specialists
Meet CION's colon cancer specialists. Bring your colonoscopy, scan or biopsy report.
Our surgical and medical oncologists plan colon cancer care together: which operation, whether chemotherapy is needed, and the follow-up that comes after.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Colon Cancer Treatment (PDQ), Health Professional Version
- American Cancer Society — Colon Cancer Treatment, by Stage
- American Cancer Society — Colorectal Cancer Chemotherapy
- NICE — Colorectal cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Do you need chemotherapy after surgery?The question that comes before the lengthWhich chemotherapy regimen for which situationCAPOX, FOLFOX or capecitabine alone, and whyHow soon after surgery should chemotherapy start?Timing matters as much as lengthTreatment for stage 3 colon cancerThe whole plan for stage 3, in one place
Talk to us
Not sure whether three months or six is right for you?
Send us your pathology report and we will ask a CION medical oncologist to explain what it means for the length of your chemotherapy. One helpline serves every CION centre.